ZANETTA BRYANT: Open Payments
NPI 1114332657 · NEWNAN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$557 in 25 payments from 16 companies in 2025. Trend: 2023 $2,693 · 2024 $1,490 · 2025 $557
Food & beverage: $557
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 3 | $72 |
| Novartis Pharmaceuticals Corporation | 3 | $64 |
| GE HEALTHCARE | 2 | $61 |
| Novo Nordisk Inc | 3 | $60 |
| ABBVIE INC. | 3 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $31 |
| MDD US Operations, LLC | 1 | $31 |
| Janssen Biotech, Inc. | 1 | $24 |
| SpringWorks Therapeutics, Inc. | 1 | $22 |
Products named: KESIMPTA, Ozempic, Rystiggo, HYQVIA, REXULTI, QULIPTA, GOMEKLI, Gamunex-C.
Industry payments across GA — which companies pay providers there.
